Chimeric antigen receptor-modified T cells against several target antigens in multiple myeloma

被引：1
|
作者：
Chang, Lung-Ji [1 ]
Liu, Yuchen [1 ]
Kuo, Hao-Hsiang [1 ]
Tsao, Shih-Ting [1 ]
Moreb, Jan S. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3149
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Galunisertib enhances chimeric antigen receptor-modified T cell function
    Wang, Zhixiong
    Liu, Qian
    Risu, Na
    Fu, Jiayu
    Zou, Yan
    Tang, Jiaxing
    Li, Long
    Liu, Hui
    Zhou, Guomin
    Zhu, Xuekai
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 3 - 13
  • [32] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Ying, Zhitao
    He, Ting
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Wu, Meng
    Feng, Feier
    Leng, Xin
    Du, Tingting
    Qi, Feifei
    Hu, Xuelian
    Ding, Yanping
    Lu, Xin-an
    Song, Yuqin
    Zhu, Jun
    BMC CANCER, 2021, 21 (01)
  • [33] Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
    Wen, Hairuo
    Qu, Zhe
    Yan, Yujing
    Pu, Chengfei
    Wang, Chao
    Jiang, Hua
    Hou, Tiantian
    Huo, Yan
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)
  • [34] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Zhitao Ying
    Ting He
    Xiaopei Wang
    Wen Zheng
    Ningjing Lin
    Meifeng Tu
    Yan Xie
    Lingyan Ping
    Chen Zhang
    Weiping Liu
    Lijuan Deng
    Meng Wu
    Feier Feng
    Xin Leng
    Tingting Du
    Feifei Qi
    Xuelian Hu
    Yanping Ding
    Xin-an Lu
    Yuqin Song
    Jun Zhu
    BMC Cancer, 21
  • [35] Efficient derivation of chimeric-antigen receptor-modified TSCM cells
    Kranz, Emiko
    Kuhlmann, Charles J.
    Chan, Joshua
    Kim, Patrick Y.
    Chen, Irvin S. Y.
    Kamata, Masakazu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
    Globerson-Levin, Anat
    Waks, Tova
    Eshhar, Zelig
    MOLECULAR THERAPY, 2014, 22 (05) : 1029 - 1038
  • [37] Chimeric Antigen Receptor-Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond
    Riddell, Stanley R.
    Jensen, Michael C.
    June, Carl H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : S2 - S5
  • [38] Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
    Berger, Carolina
    Sommermeyer, Daniel
    Hudecek, Michael
    Berger, Michael
    Balakrishnan, Ashwini
    Paszkiewicz, Paulina J.
    Kosasih, Paula L.
    Rader, Christoph
    Riddell, Stanley R.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (02) : 206 - 216
  • [39] Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer
    Yin, Li
    Chen, Gui-lai
    Xiang, Zhuo
    Liu, Yu-lin
    Li, Xing-yu
    Bi, Jing-wang
    Wang, Qiang
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [40] Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
    Yanyu Pang
    Xiaoyang Hou
    Chunsheng Yang
    Yanqun Liu
    Guan Jiang
    Molecular Cancer, 17
12345